ATAI Life Sciences NV
NASDAQ:ATAI
ATAI Life Sciences NV
NASDAQ:ATAI
Price:
3.74
USD
-5.32%
Market Closed
Market Cap:
$1.4B
Income Statement
Earnings Waterfall
ATAI Life Sciences NV
ATAI Life Sciences NV
Income Statement
ATAI Life Sciences NV
ATAI Life Sciences NV
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
0
|
|
| Revenue |
0
N/A
|
20
N/A
|
20
N/A
|
20
+1%
|
20
+1%
|
1
-98%
|
1
+34%
|
0
-37%
|
0
-45%
|
0
+17%
|
0
N/A
|
0
+26%
|
0
-8%
|
0
-11%
|
0
+37%
|
0
-13%
|
2
+464%
|
2
+24%
|
3
+31%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(92)
|
(103)
|
(151)
|
(177)
|
(141)
|
(159)
|
(141)
|
(146)
|
(145)
|
(143)
|
(141)
|
(130)
|
(123)
|
(115)
|
(109)
|
(107)
|
(69)
|
(69)
|
(76)
|
|
| Selling, General & Administrative |
(81)
|
(88)
|
(123)
|
(139)
|
(93)
|
(101)
|
(81)
|
(81)
|
(70)
|
(66)
|
(66)
|
(60)
|
(62)
|
(61)
|
(57)
|
(54)
|
(34)
|
(35)
|
(40)
|
|
| Research & Development |
(11)
|
(15)
|
(28)
|
(38)
|
(48)
|
(58)
|
(60)
|
(65)
|
(74)
|
(78)
|
(76)
|
(70)
|
(60)
|
(54)
|
(51)
|
(50)
|
(36)
|
(34)
|
(36)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
|
| Operating Income |
(92)
N/A
|
(83)
+9%
|
(131)
-57%
|
(157)
-20%
|
(120)
+23%
|
(159)
-32%
|
(140)
+12%
|
(145)
-4%
|
(144)
+1%
|
(143)
+1%
|
(141)
+1%
|
(129)
+8%
|
(122)
+6%
|
(114)
+6%
|
(108)
+5%
|
(107)
+1%
|
(68)
+37%
|
(67)
+1%
|
(73)
-9%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
20
|
0
|
(5)
|
2
|
(3)
|
(0)
|
10
|
8
|
7
|
5
|
(0)
|
64
|
(2)
|
(1)
|
(1)
|
(70)
|
(1)
|
5
|
5
|
|
| Non-Reccuring Items |
(13)
|
(13)
|
(22)
|
(22)
|
(16)
|
(15)
|
(7)
|
(7)
|
1
|
0
|
1
|
1
|
(4)
|
(3)
|
(3)
|
0
|
(1)
|
(2)
|
(2)
|
|
| Total Other Income |
(17)
|
(17)
|
(16)
|
(2)
|
3
|
(0)
|
(0)
|
(0)
|
1
|
2
|
3
|
4
|
89
|
87
|
55
|
50
|
(41)
|
(16)
|
(45)
|
|
| Pre-Tax Income |
(102)
N/A
|
(114)
-12%
|
(174)
-53%
|
(179)
-3%
|
(137)
+24%
|
(174)
-28%
|
(138)
+21%
|
(144)
-5%
|
(135)
+6%
|
(136)
-1%
|
(137)
-1%
|
(60)
+56%
|
(39)
+35%
|
(32)
+19%
|
(57)
-80%
|
(128)
-123%
|
(110)
+14%
|
(80)
+27%
|
(115)
-43%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(1)
|
4
|
4
|
4
|
4
|
(6)
|
(6)
|
(7)
|
(7)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(102)
|
(114)
|
(174)
|
(180)
|
(133)
|
(170)
|
(134)
|
(140)
|
(141)
|
(143)
|
(144)
|
(67)
|
(40)
|
(33)
|
(58)
|
(128)
|
(110)
|
(80)
|
(115)
|
|
| Income to Minority Interest |
9
|
5
|
9
|
10
|
6
|
10
|
6
|
8
|
5
|
6
|
5
|
4
|
4
|
3
|
2
|
2
|
0
|
0
|
0
|
|
| Equity Earnings Affiliates |
(77)
|
(76)
|
(52)
|
5
|
(42)
|
(46)
|
(66)
|
(64)
|
(16)
|
(11)
|
(7)
|
(5)
|
(4)
|
(4)
|
(3)
|
(2)
|
(0)
|
(0)
|
0
|
|
| Net Income (Common) |
(170)
N/A
|
(185)
-9%
|
(218)
-17%
|
(166)
+24%
|
(168)
-1%
|
(205)
-22%
|
(194)
+6%
|
(196)
-1%
|
(152)
+22%
|
(149)
+2%
|
(145)
+2%
|
(67)
+54%
|
(40)
+40%
|
(34)
+16%
|
(58)
-72%
|
(129)
-121%
|
(110)
+14%
|
(80)
+27%
|
(115)
-43%
|
|
| EPS (Diluted) |
-1.11
N/A
|
-1.23
-11%
|
-1.64
-33%
|
-1.09
+34%
|
-1.21
-11%
|
-1.33
-10%
|
-1.25
+6%
|
-1.25
N/A
|
-0.98
+22%
|
-0.95
+3%
|
-0.92
+3%
|
-0.37
+60%
|
-0.25
+32%
|
-0.21
+16%
|
-0.36
-71%
|
-0.8
-122%
|
-0.62
+23%
|
-0.4
+35%
|
-0.52
-30%
|
|
Switch to:
Switch to:
See Also
Discover More
